Living donor transplantation offers a safe alternative for liver transplant patients
Amsterdam, September 26, 2022 – Demand for donor livers for transplant patients outstrips supply with over 15% of waitlist patients dying after a year. A new international study offers support for increasing…
Introducing the new EASL Membership structure
From the very beginning, EASL’s mission has been to be the “Home of Hepatology”. Providing education to everyone interested in hepatology and engaging with all stakeholders in the liver field wherever they…
Treatment in Pregnancy for Hepatitis C (TiP-HepC) Clinical Case Registry
Although DAA medications have demonstrated excellent safety and efficacy in non-pregnant individuals, they are not currently approved for HCV treatment in pregnant women due to a lack of safety data. Clinical trials…
Instagram Contest: Join the MOVEment!
Follow us @easl.news on Instagram Like the contest post Comment under the post how you are joining the MOVEment against NAFLD Post a Story showing how you fight NAFLD by tagging us…
NAFLD Nomenclature Consensus Meeting High-Level Output
The 2-day meeting in Chicago on 8-9 July 2022 convened 129 consensus survey participants in person or online. The participants originated from 32 countries, representing multiple societies including AASLD, EASL, APASL, ALEH,…
Call to host an EASL School of Hepatology 2024
EASL is opening the call for hosting three clinical and one basic EASL School to be held in 2024. If you are an EASL Member, submit your proposal before 30 September 2022.
Liver disease UK deaths soar by 400% since 1970
28 July 2022